Introduction: Despite the essential utility of opioids for the clinical management of pain, opioid-induced constipation (OIC) remains an important obstacle in clinical practice. In patients, OIC hinders treatment compliance and has negative effects on quality of life. From a clinician perspective, the diagnosis and management of OIC are hampered by the absence of a clear, universal diagnostic definition across disciplines and a lack of standardization in OIC treatment and assessment. Methods: A multidisciplinary panel of physician experts who treat OIC was assembled to identify a list of ten corrective actions-five "things to do" and five "things not to do"-for the diagnosis and management of OIC, utilizing the Choosing Wisely methodology. Results: The final list of corrective actions to improve the diagnosis and clinical management of OIC emphasized a need for: (i) better physician and patient education regarding OIC; (ii) systematic use of diagnostically validated approaches to OIC diagnosis and assessment (i.e., Rome IV criteria and Bristol Stool Scale, respectively) across various medical contexts; and (iii) awareness about appropriate, evidence-based treatments for OIC including available peripheral mu-opioid receptor antagonists (PAMORAs). Conclusions: Physicians who prescribe long-term opioids should be forthcoming with patients about the possibility of OIC and be adequately versed in the most recent guideline recommendations for its management.

What to do and what not to do in the management of opioid-induced constipation. A Choosing Wisely report / Alvaro, Domenico; Caraceni, Augusto Tommaso; Coluzzi, Flaminia; Gianni, Walter; Lugoboni, Fabio; Marinangeli, Franco; Massazza, Giuseppe; Pinto, Carmine; Varrassi, Giustino. - In: PAIN AND THERAPY. - ISSN 2193-8237. - 9:2(2020), pp. 657-667. [10.1007/s40122-020-00195-z]

What to do and what not to do in the management of opioid-induced constipation. A Choosing Wisely report

Alvaro, Domenico
Primo
Membro del Collaboration Group
;
Coluzzi, Flaminia
Membro del Collaboration Group
;
Gianni, Walter
Membro del Collaboration Group
;
2020

Abstract

Introduction: Despite the essential utility of opioids for the clinical management of pain, opioid-induced constipation (OIC) remains an important obstacle in clinical practice. In patients, OIC hinders treatment compliance and has negative effects on quality of life. From a clinician perspective, the diagnosis and management of OIC are hampered by the absence of a clear, universal diagnostic definition across disciplines and a lack of standardization in OIC treatment and assessment. Methods: A multidisciplinary panel of physician experts who treat OIC was assembled to identify a list of ten corrective actions-five "things to do" and five "things not to do"-for the diagnosis and management of OIC, utilizing the Choosing Wisely methodology. Results: The final list of corrective actions to improve the diagnosis and clinical management of OIC emphasized a need for: (i) better physician and patient education regarding OIC; (ii) systematic use of diagnostically validated approaches to OIC diagnosis and assessment (i.e., Rome IV criteria and Bristol Stool Scale, respectively) across various medical contexts; and (iii) awareness about appropriate, evidence-based treatments for OIC including available peripheral mu-opioid receptor antagonists (PAMORAs). Conclusions: Physicians who prescribe long-term opioids should be forthcoming with patients about the possibility of OIC and be adequately versed in the most recent guideline recommendations for its management.
2020
Bristol stool scale; chronic constipation; opioid-induced constipation; peripheral mu-opioid receptor antagonist; Rome IV criteria
01 Pubblicazione su rivista::01a Articolo in rivista
What to do and what not to do in the management of opioid-induced constipation. A Choosing Wisely report / Alvaro, Domenico; Caraceni, Augusto Tommaso; Coluzzi, Flaminia; Gianni, Walter; Lugoboni, Fabio; Marinangeli, Franco; Massazza, Giuseppe; Pinto, Carmine; Varrassi, Giustino. - In: PAIN AND THERAPY. - ISSN 2193-8237. - 9:2(2020), pp. 657-667. [10.1007/s40122-020-00195-z]
File allegati a questo prodotto
File Dimensione Formato  
Alvaro_What-to-do_2020.pdf

accesso aperto

Note: https://link.springer.com/article/10.1007/s40122-020-00195-z
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 569.92 kB
Formato Adobe PDF
569.92 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1481520
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 0
social impact